Comprehensive FDA and EMA-approved therapy profiles, active clinical trials, molecular biology, and SEER statistics across 50 cancer types — built for patients, caregivers, and oncology professionals.
Our deepest therapeutic coverage — with the most approved drugs, clinical trials, and editorial analysis.
218+ approved therapies with brand/generic names, mechanism of action, approved indications, dosing, pivotal trial data, and regulatory status across both US and European markets.
Tumor-specific genomic landscapes, actionable mutations, biomarker testing guidance, and molecular subtyping for personalized treatment selection.
Population-level incidence, mortality, survival by stage, demographic breakdowns, and trends from the NCI SEER program for 26 major tumor types.
600+ active Phase 1-3 trials with NCT/EudraCT numbers, interventions, endpoints, and direct links to ClinicalTrials.gov and EU registries.
Tumor-specific epidemiology, evolving treatment landscapes, and frequently asked questions with structured schema markup across all 50 tumor types.
Both FDA and EMA regulatory data with direct links to US and European clinical trial registries for a comprehensive global treatment perspective.
Select any tumor type to explore approved therapies, clinical trials, molecular biology, and epidemiological data.
In-depth guides covering key concepts in modern cancer treatment.
How checkpoint inhibitors work, which cancers respond best, and biomarkers guiding treatment selection.
Treatment GuideThe guided missiles of cancer therapy — how ADCs deliver chemotherapy directly to cancer cells.
ScienceFrom molecular profiling to targeted treatment — how genomics is transforming cancer care.
Whether you're a patient researching treatment options, a caregiver seeking clarity, or a clinician reviewing the evidence — access comprehensive oncology intelligence across 50 tumor types.
Browse FDA and EMA-approved therapies across 50 cancer types